{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:21Z","timestamp":1791357261061,"version":"4.3.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T00:00:00Z","timestamp":1459209600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00228-016-2044-y","type":"journal-article","created":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T03:31:37Z","timestamp":1459222297000},"page":"869-876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Comorbidities and concurrent medications increasing the risk of adverse drug reactions: prevalence in French benzodiazepine users"],"prefix":"10.1007","volume":"72","author":[{"given":"Anne","family":"B\u00e9nard-Laribi\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernelle","family":"Noize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Pambrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Bazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Verdoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"B\u00e9gaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pariente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,29]]},"reference":[{"key":"2044_CR1","unstructured":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9 (2012) Etat des lieux de la consommation des benzodiaz\u00e9pines en France. http:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Etat-des-lieux-en-2013-de-la-consommation-des-benzodiazepines-en-France-Point-d-Information . Accessed 11 Nov 2015"},{"key":"2044_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3825","author":"C Huerta","year":"2015","unstructured":"Huerta C, Abbing-Karahagopian V, Requena G, Oliva B, Alvarez Y, Gardarsdottir H, Miret M, Schneider C, Gil M, Souverein PC, De Bruin ML, Slattery J, De Groot MC, Hesse U, Rottenkolber M, Schmiedl S, Montero D, Bate A, Ruigomez A, Garcia-Rodriguez LA, Johansson S, de Vries F, Schlienger RG, Reynolds RF, Klungel OH, de Abajo FJ (2015) Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. doi: 10.1002\/pds.3825","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"2044_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00228-012-1424-1","volume":"69","author":"E Clay","year":"2013","unstructured":"Clay E, Falissard B, Moore N, Toumi M (2013) Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries. Eur J Clin Pharmacol 69(4):1\u201310. doi: 10.1007\/s00228-012-1424-1","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2044_CR4","doi-asserted-by":"publisher","first-page":"E208","DOI":"10.9778\/cmajo.20130076","volume":"2","author":"S Alessi-Severini","year":"2014","unstructured":"Alessi-Severini S, Bolton JM, Enns MW, Dahl M, Collins DM, Chateau D, Sareen J (2014) Use of benzodiazepines and related drugs in Manitoba: a population-based study. CMAJ Open 2(4):E208\u2013E216. doi: 10.9778\/cmajo.20130076","journal-title":"CMAJ Open"},{"issue":"2","key":"2044_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M (2015) Benzodiazepine use in the United States. JAMA Psychiatry 72(2):136\u2013142. doi: 10.1001\/jamapsychiatry.2014.1763","journal-title":"JAMA Psychiatry"},{"key":"2044_CR6","volume-title":"Rang and Dale\u2019s pharmacology","author":"HP Rang","year":"2012","unstructured":"Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G (2012) Rang and Dale\u2019s pharmacology, 7th edn. Elsevier Churchill Livingstone, Edinburgh","edition":"7"},{"issue":"6","key":"2044_CR7","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","volume":"23","author":"BR Celli","year":"2004","unstructured":"Celli BR, MacNee W, Force AET (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper. Eur Respir J 23(6):932\u2013946","journal-title":"Eur Respir J"},{"key":"2044_CR8","unstructured":"Sweetman SC (ed) Martindale: The complete drug reference. [online] Pharmaceutical Press, London http:\/\/www.micromedexsolutions.com\/home\/dispatch . Accessed 12 Feb 2016"},{"issue":"1","key":"2044_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00002512-200825010-00007","volume":"25","author":"A Pariente","year":"2008","unstructured":"Pariente A, Dartigues JF, Benichou J, Letenneur L, Moore N, Fourrier-Reglat A (2008) Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 25(1):61\u201370","journal-title":"Drugs Aging"},{"issue":"7288","key":"2044_CR10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bmj.322.7288.704","volume":"322","author":"C Pierfitte","year":"2001","unstructured":"Pierfitte C, Macouillard G, Thicoipe M, Chaslerie A, Pehourcq F, Aissou M, Martinez B, Lagnaoui R, Fourrier A, Begaud B, Dangoumau J, Moore N (2001) Benzodiazepines and hip fractures in elderly people: case-control study. BMJ 322(7288):704\u2013708","journal-title":"BMJ"},{"issue":"4","key":"2044_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/clpt.2011.3","volume":"89","author":"L Orriols","year":"2011","unstructured":"Orriols L, Philip P, Moore N, Castot A, Gadegbeku B, Delorme B, Mallaret M, Lagarde E, Group CR (2011) Benzodiazepine-like hypnotics and the associated risk of road traffic accidents. Clin Pharmacol Ther 89(4):595\u2013601. doi: 10.1038\/clpt.2011.3","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"2044_CR12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2165\/11533170-000000000-00000","volume":"24","author":"BE Smink","year":"2010","unstructured":"Smink BE, Egberts AC, Lusthof KJ, Uges DR, de Gier JJ (2010) The relationship between benzodiazepine use and traffic accidents: a systematic literature review. CNS Drugs 24(8):639\u2013653. doi: 10.2165\/11533170-000000000-00000","journal-title":"CNS Drugs"},{"key":"2044_CR13","doi-asserted-by":"publisher","first-page":"e6231","DOI":"10.1136\/bmj.e6231","volume":"345","author":"S Billioti de Gage","year":"2012","unstructured":"Billioti de Gage S, Begaud B, Bazin F, Verdoux H, Dartigues JF, Peres K, Kurth T, Pariente A (2012) Benzodiazepine use and risk of dementia: prospective population based study. BMJ 345:e6231. doi: 10.1136\/bmj.e6231","journal-title":"BMJ"},{"key":"2044_CR14","doi-asserted-by":"publisher","first-page":"g5205","DOI":"10.1136\/bmj.g5205","volume":"349","author":"S Billioti de Gage","year":"2014","unstructured":"Billioti de Gage S, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, Pariente A, Begaud B (2014) Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study. BMJ 349:g5205. doi: 10.1136\/bmj.g5205","journal-title":"BMJ"},{"key":"2044_CR15","unstructured":"European Medicines Agency (1994) Summary of product characteristics for benzodiazepines as anxiolytics or hypnotics. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003774.pdf . Accessed 10 Nov 2015"},{"issue":"4 Suppl","key":"2044_CR16","doi-asserted-by":"publisher","first-page":"43S","DOI":"10.1378\/chest.08-0342","volume":"134","author":"J Maurer","year":"2008","unstructured":"Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA, Anxiety AWPo, Depression in C (2008) Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 134(4 Suppl):43S\u201356S. doi: 10.1378\/chest.08-0342","journal-title":"Chest"},{"issue":"3","key":"2044_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1136\/thx.2009.126201","volume":"65","author":"MD Eisner","year":"2010","unstructured":"Eisner MD, Blanc PD, Yelin EH, Katz PP, Sanchez G, Iribarren C, Omachi TA (2010) Influence of anxiety on health outcomes in COPD. Thorax 65(3):229\u2013234. doi: 10.1136\/thx.2009.126201","journal-title":"Thorax"},{"issue":"18","key":"2044_CR18","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1001\/archinte.164.18.1957","volume":"164","author":"JH Gurwitz","year":"2004","unstructured":"Gurwitz JH (2004) Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med 164(18):1957\u20131959. doi: 10.1001\/archinte.164.18.1957","journal-title":"Arch Intern Med"},{"issue":"6","key":"2044_CR19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1517\/14740338.6.6.695","volume":"6","author":"JA Salazar","year":"2007","unstructured":"Salazar JA, Poon I, Nair M (2007) Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable. Expert Opin Drug Saf 6(6):695\u2013704. doi: 10.1517\/14740338.6.6.695","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"2044_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/fcp.12088","volume":"29","author":"A Benard-Laribiere","year":"2015","unstructured":"Benard-Laribiere A, Miremont-Salame G, Perault-Pochat MC, Noize P, Haramburu F, centres ESGobotFnop (2015) Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study. Fundam Clin Pharmacol 29(1):106\u2013111. doi: 10.1111\/fcp.12088","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"2044_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.respe.2010.04.005","volume":"58","author":"P Tuppin","year":"2010","unstructured":"Tuppin P, de Roquefeuil L, Weill A, Ricordeau P, Merliere Y (2010) French national health insurance information system and the permanent beneficiaries sample. Rev Epidemiol Sante Publique 58(4):286\u2013290. doi: 10.1016\/j.respe.2010.04.005","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"4","key":"2044_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00228-013-1614-5","volume":"70","author":"J Bezin","year":"2014","unstructured":"Bezin J, Pariente A, Lassalle R, Dureau-Pournin C, Abouelfath A, Robinson P, Moore N, Droz-Perroteau C, Fourrier-Reglat A (2014) Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France. Eur J Clin Pharmacol 70(4):429\u2013436. doi: 10.1007\/s00228-013-1614-5","journal-title":"Eur J Clin Pharmacol"},{"key":"2044_CR23","unstructured":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9 (2012) Plan d\u2019actions de l\u2019ANSM visant \u00e0 r\u00e9duire le m\u00e9susage des benzodiaz\u00e9pines. http:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Plan-d-actions-de-l-ANSM-visant-a-reduire-le-mesusage-des-benzodiazepines-Point-d-information . Accessed 10 Nov 2015"},{"key":"2044_CR24","unstructured":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9 (2013) Etat des lieux de la consommation des benzodiaz\u00e9pines en France. http:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Etat-des-lieux-en-2013-de-la-consommation-des-benzodiazepines-en-France-Point-d-Information . Accessed 11 Nov 2015"},{"key":"2044_CR25","doi-asserted-by":"publisher","first-page":"h2698","DOI":"10.1136\/bmj.h2698","volume":"350","author":"TW Park","year":"2015","unstructured":"Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS (2015) Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ 350:h2698. doi: 10.1136\/bmj.h2698","journal-title":"BMJ"},{"issue":"10","key":"2044_CR26","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1111\/pme.12787","volume":"16","author":"EJ Hawkins","year":"2015","unstructured":"Hawkins EJ, Malte CA, Grossbard JR, Saxon AJ (2015) Prevalence and trends of concurrent opioid analgesic and benzodiazepine use among veterans affairs patients with post-traumatic stress disorder, 2003\u20132011. Pain Med 16(10):1943\u20131954. doi: 10.1111\/pme.12787","journal-title":"Pain Med"},{"issue":"1","key":"2044_CR27","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.36076\/ppj.2013\/16\/E1","volume":"16","author":"L Manchikanti","year":"2013","unstructured":"Manchikanti L, Cash KA, Malla Y, Pampati V, Fellows B (2013) A prospective evaluation of psychotherapeutic and illicit drug use in patients presenting with chronic pain at the time of initial evaluation. Pain Physician 16(1):E1\u2013E13","journal-title":"Pain Physician"},{"issue":"2","key":"2044_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/pme.12594","volume":"16","author":"S Nielsen","year":"2015","unstructured":"Nielsen S, Lintzeris N, Bruno R, Campbell G, Larance B, Hall W, Hoban B, Cohen ML, Degenhardt L (2015) Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization. Pain Med 16(2):356\u2013366. doi: 10.1111\/pme.12594","journal-title":"Pain Med"},{"issue":"10","key":"2044_CR29","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/archdischild-2014-307224","volume":"100","author":"A Benard-Laribiere","year":"2015","unstructured":"Benard-Laribiere A, Jove J, Lassalle R, Robinson P, Droz-Perroteau C, Noize P (2015) Drug use in French children: a population-based study. Arch Dis Child 100(10):960\u2013965. doi: 10.1136\/archdischild-2014-307224","journal-title":"Arch Dis Child"},{"key":"2044_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-0047.2004.00331.x","volume":"420","author":"J Alonso","year":"2004","unstructured":"Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lepine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martinez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacin C, Romera B, Taub N, Vollebergh WA, EsemeD\/Mhedea Investigators ESotEoMDP (2004) Psychotropic drug utilization in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 420:55\u201364. doi: 10.1111\/j.1600-0047.2004.00331.x","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"9","key":"2044_CR31","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4088\/JCP.v63n0912","volume":"63","author":"MM Ohayon","year":"2002","unstructured":"Ohayon MM, Lader MH (2002) Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 63(9):817\u2013825","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"2044_CR32","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/gps.2569","volume":"26","author":"CM Chang","year":"2011","unstructured":"Chang CM, Chen MJ, Tsai CY, Ho LH, Hsieh HL, Chau YL, Liu CY (2011) Medical conditions and medications as risk factors of falls in the inpatient older people: a case-control study. Int J Geriatr Psychiatry 26(6):602\u2013607. doi: 10.1002\/gps.2569","journal-title":"Int J Geriatr Psychiatry"},{"issue":"21","key":"2044_CR33","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","volume":"169","author":"JC Woolcott","year":"2009","unstructured":"Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, Marra CA (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169(21):1952\u20131960. doi: 10.1001\/archinternmed.2009.357","journal-title":"Arch Intern Med"},{"issue":"2","key":"2044_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P (2015) STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44(2):213\u2013218. doi: 10.1093\/ageing\/afu145","journal-title":"Age Ageing"},{"issue":"4","key":"2044_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187(4):347\u2013365. doi: 10.1164\/rccm.201204-0596PP","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2044_CR36","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1183\/09031936.00008014","volume":"44","author":"NT Vozoris","year":"2014","unstructured":"Vozoris NT, Fischer HD, Wang X, Stephenson AL, Gershon AS, Gruneir A, Austin PC, Anderson GM, Bell CM, Gill SS, Rochon PA (2014) Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J 44(2):332\u2013340. doi: 10.1183\/09031936.00008014","journal-title":"Eur Respir J"},{"issue":"3","key":"2044_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s40266-013-0056-1","volume":"30","author":"NT Vozoris","year":"2013","unstructured":"Vozoris NT, Fischer HD, Wang X, Anderson GM, Bell CM, Gershon AS, Stephenson AL, Gill SS, Rochon PA (2013) Benzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort study. Drugs Aging 30(3):183\u2013192. doi: 10.1007\/s40266-013-0056-1","journal-title":"Drugs Aging"},{"key":"2044_CR38","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.2147\/COPD.S83107","volume":"10","author":"T Halvorsen","year":"2015","unstructured":"Halvorsen T, Martinussen PE (2015) Benzodiazepine use in COPD: empirical evidence from Norway. Int J Chron Obstruct Pulmon Dis 10:1695\u20131702. doi: 10.2147\/COPD.S83107","journal-title":"Int J Chron Obstruct Pulmon Dis"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2044-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-016-2044-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2044-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T13:11:25Z","timestamp":1655385085000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-016-2044-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,29]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["2044"],"URL":"https:\/\/doi.org\/10.1007\/s00228-016-2044-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,29]]}}}